what are the risks of taking semaglutide Therapeutic Goods Administration has issued an urgent safety warning over the risk suicidal thoughts linked to popular drugs used to treat type 2 diabetes and obesity. The affected drugs include Who Should Not Take Semaglutide?

Symptoms include: Fatigue and weakness Chronic burning in the throat and nasal passages Coughing, wheezing, and shortness of breath Loss of balance Depression and/or anxiety Skin rashes Eye irritation or tearing of the eyes Headache and/or light sensitivity Hearing loss Heightened sensitivity to chemicals and foods Irregular heartbeat Morning stiffness and/or joint pain Muscle weakness Sleep problems Poor memory, difficulty finding words Slower reaction time Vision changes Difficulty concentrating Abdominal pain, diarrhea, and/or bloating Unusual skin sensations, tingling, and numbness Increased urinary frequency or increased thirst Disorientation and/or dizziness Static shocks or metallic taste in the mouth Additionally, mycotoxin toxicity is linked explicitly to neurological symptoms, with patients reporting cognitive, emotional, and behavioral effects

what changes is the patients experience

Semaglutide , taken weekly: Possibly the most well-known of them all, FDA-approved under the brand names Ozempic for type 2 diabetes and to reduce the risk of a major adverse cardiovascular event in adults with type 2 diabetes or an established cardiovascular disease and Wegovy for obesity

Do not use this as a daily supplement

We provide practical nutrition guidance tailored to your lifestyle